SL
Therapeutic Areas
Theradiag Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lisa-Tracker Extensions | Autoimmune Diseases | Development/CE Marking |
| Prestizia Oncology Panels | Solid Tumors | Commercial/Market Expansion |
| Digital PCR Assay Development | Oncology & Infectious Diseases | R&D/Validation |
| Companion Diagnostic Co-Development | Oncology Targets | Partnership/Regulatory |